Last reviewed · How we verify

NCT07295782

The Assessment of Fibrin Clot Phenotype and Thrombin Generation in Women After Urogynecological Surgeries.

Recruiting now Last updated 22 December 2025
What this trial tests

trial testing determination of fibrin clot properties in Uterine Prolapse in 60 participants. Currently enrolling.

Timeline
10 December 2025
Primary endpoint
30 May 2026
30 May 2026

Quick facts

Lead sponsorJagiellonian University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date10 December 2025
Primary completion30 May 2026
Estimated completion30 May 2026
Sites1 location across Poland

Drugs / interventions tested

Conditions studied

Sponsor

Jagiellonian University

Who can join

Adults 18 to 70, female only, with Uterine Prolapse or Urine Incontinence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Determination of fibrin clot properties along with thrombin generation in women after urigynecological surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Uterine Prolapse

Currently open trials in the same condition.

Other Jagiellonian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07295782.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing